The FDA approved remdesivir as a treatment for severe COVID-19 cases last month.<br />This is after granting emergency authorization in May, reports Business Insider.<br />But on Thursday, the WHO announced it will not recommend the drug's use for COVID-19 patients.<br />"There is currently no evidence that it improves survival or the need for ventilation," the organization said.<br />Remdesivir was the first coronavirus treatment to receive emergency authorization from the FDA.<br />With Pfizer and Moderna's vaccines on the horizon, there is less of a need for weaker treatments.
